Clinical Trial Update: Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/Phase 2 clinical trial evaluating allogeneic culture-expanded bone marrow-derived mesenchymal stem cells for systolic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Allogeneic culture-expanded bone marrow-derived mesenchymal stem cells (Mesenchymal stem cells (allogeneic, culture-expanded, bone marrow-derived))

Snippet

Sponsor: BioCardia, Inc. | Conditions: Heart Failure, Systolic | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING